208 related articles for article (PubMed ID: 21969138)
41. Downregulation and DNA methylation of ECRG4 in gastric cancer.
Deng P; Chang XJ; Gao ZM; Xu XY; Sun AQ; Li K; Dai DQ
Onco Targets Ther; 2018; 11():4019-4028. PubMed ID: 30034241
[TBL] [Abstract][Full Text] [Related]
42. Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells.
Agarwal R; Mori Y; Cheng Y; Jin Z; Olaru AV; Hamilton JP; David S; Selaru FM; Yang J; Abraham JM; Montgomery E; Morin PJ; Meltzer SJ
PLoS One; 2009 Nov; 4(11):e8002. PubMed ID: 19956721
[TBL] [Abstract][Full Text] [Related]
43. Epigenetic silencing of dual oxidase 1 by promoter hypermethylation in human hepatocellular carcinoma.
Ling Q; Shi W; Huang C; Zheng J; Cheng Q; Yu K; Chen S; Zhang H; Li N; Chen M
Am J Cancer Res; 2014; 4(5):508-17. PubMed ID: 25232492
[TBL] [Abstract][Full Text] [Related]
44. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome.
Ma G; Liu H; Hua Q; Wang M; Du M; Lin Y; Ge Y; Gong W; Zhao Q; Qiang F; Tao G; Zhang Z; Chu H
Mol Cancer; 2017 Feb; 16(1):46. PubMed ID: 28231797
[TBL] [Abstract][Full Text] [Related]
45. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
[TBL] [Abstract][Full Text] [Related]
46. Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer.
Liu X; Lam EK; Wang X; Zhang J; Cheng YY; Lam YW; Ng EK; Yu J; Chan FK; Jin H; Sung JJ
Tumour Biol; 2009; 30(5-6):242-8. PubMed ID: 19816091
[TBL] [Abstract][Full Text] [Related]
47. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
[TBL] [Abstract][Full Text] [Related]
48. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
Yu J; Liang Q; Wang J; Wang K; Gao J; Zhang J; Zeng Y; Chiu PW; Ng EK; Sung JJ
Oncogene; 2017 Jan; 36(2):182-193. PubMed ID: 27212034
[TBL] [Abstract][Full Text] [Related]
49. Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancer.
Chen Z; Hu T; Zhu S; Mukaisho K; El-Rifai W; Peng DF
Oncotarget; 2017 Aug; 8(33):54345-54356. PubMed ID: 28903346
[TBL] [Abstract][Full Text] [Related]
50. Role of PTCH1 gene methylation in gastric carcinogenesis.
Zuo Y; Song Y; Zhang M; Xu Z; Qian X
Oncol Lett; 2014 Aug; 8(2):679-682. PubMed ID: 25013484
[TBL] [Abstract][Full Text] [Related]
51. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
[TBL] [Abstract][Full Text] [Related]
52. Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.
Yang T; Qiu H; Bao W; Li B; Lu C; Du G; Luo X; Wang L; Wan X
PLoS One; 2013; 8(6):e67458. PubMed ID: 23840707
[TBL] [Abstract][Full Text] [Related]
53. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
54. Analysis of genes upregulated by the demethylating agent 5-aza-2'-deoxycytidine in gastric cancer cell lines.
Mikata R; Yokosuka O; Fukai K; Imazeki F; Arai M; Tada M; Kurihara T; Zhang K; Kanda T; Saisho H
Int J Cancer; 2006 Oct; 119(7):1616-22. PubMed ID: 16671088
[TBL] [Abstract][Full Text] [Related]
55. Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer.
Dong W; Tu S; Xie J; Sun P; Wu Y; Wang L
Biochem Biophys Res Commun; 2009 Sep; 387(1):132-8. PubMed ID: 19576178
[TBL] [Abstract][Full Text] [Related]
56. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.
Yu J; Liang QY; Wang J; Cheng Y; Wang S; Poon TC; Go MY; Tao Q; Chang Z; Sung JJ
Oncogene; 2013 Jan; 32(3):307-17. PubMed ID: 22370639
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
Ramos EA; Camargo AA; Braun K; Slowik R; Cavalli IJ; Ribeiro EM; Pedrosa Fde O; de Souza EM; Costa FF; Klassen G
BMC Cancer; 2010 Jan; 10():23. PubMed ID: 20109227
[TBL] [Abstract][Full Text] [Related]
58. Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma.
Lo PH; Tanikawa C; Katagiri T; Nakamura Y; Matsuda K
Oncol Rep; 2015 Jan; 33(1):267-73. PubMed ID: 25370079
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expression.
Li D; Li Z; Xiong J; Gong B; Zhang G; Cao C; Jie Z; Liu Y; Cao Y; Yan Y; Xiong H; Qiu L; Yang M; Chen H; Jiang S; Yang X; Chen H
Am J Cancer Res; 2015; 5(10):2980-97. PubMed ID: 26693054
[TBL] [Abstract][Full Text] [Related]
60. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
